Sung-Shin Hong1, Ji-Young Lee1, Jin-Seok Lee2, Hye-Won Lee3, Hyeong-Geug Kim2, Sam-Keun Lee4, Bong-Ki Park5, Chang-Gue Son6. 1. Korean Medical College of Daejeon University, 22-5 Yongwoon-dong, Dong-gu, Daejeon 301-724, Republic of Korea. 2. Liver and Immunology Research Center, Daejeon Oriental Hospital of Daejeon University, 22-5 Daeheung-dong, Jung-gu, Daejeon 301-704, Republic of Korea. 3. TKM-based Herbal Drug Research Group, Korea Institute of Oriental Medicine, Daejeon 305-811, Republic of Korea. 4. Department of Applied Chemistry, Oriental Medicine College of Daejeon University, 62, Daehak-ro, Dong-gu, Daejeon 300-716, Republic of Korea. 5. Medical research division, Korea Institute of Oriental Medicine, Daejeon 305-811, Republic of Korea. 6. Korean Medical College of Daejeon University, 22-5 Yongwoon-dong, Dong-gu, Daejeon 301-724, Republic of Korea. Electronic address: ckson@dju.ac.kr.
Abstract
ETHNOPHARMACOLOGICAL RELEVANCE: Gongjin-Dan is a representative traditional Oriental medicine herbal drug that has been used to treat chronic fatigue symptoms for several hundred years. We evaluated the anti-fatigue effects of Gongjin-Dan and the underlying mechanisms in a chronic forced exercise mouse model. METHODS AND MATERIALS: Balb/C male mice underwent an extreme treadmill-based running stress (1-h, 5 days/week), and daily oral administration of distilled water, Gongjin-Dan (100, 200, or 400 mg/kg), or ascorbic acid (100 mg/kg) for 28 days. The anti-fatigue effects of Gongjin-Dan were evaluated with behavioral tests (exercise tolerance and swimming tests), and the corresponding mechanisms were investigated based on oxidative stress and inflammatory cytokine and stress hormone levels in skeletal muscle, sera, and brain tissue. RESULTS: Gongjin-Dan significantly increased exercise tolerance and latency times but reduced the number of electric shocks and immobilization time on the treadmill running and swimming tests, compared with the control group. Gongjin-Dan also significantly ameliorated alterations in oxidative stress-related biomarkers (reactive oxygen species and malondialdehyde), inflammatory cytokines (tumor necrosis factor-α, interleukin-1 beta, interleukin-6, and interferon-γ) and glycogen and L-lactate levels in skeletal muscle, compared with those in the control group. Moreover, Gongjin-Dan considerably normalized the forced running stress-induced changes in serum corticosterone and adrenaline levels, as well as brain serotonin level. These antioxidant and anti-stress effects of Gongjin-Dan were supported by the results of Western blotting (4-hydroxynonenal and heme oxygenase-1) and the gene expression levels (serotonin receptor and serotonin transporter). CONCLUSION: These results support the clinical relevance of Gongjin-Dan regarding anti-chronic fatigue properties. The underlying mechanisms involve attenuation of oxidative and inflammatory reactions in muscle and regulation of the stress response through the hypothalmo-pituitary-adrenal axis.
ETHNOPHARMACOLOGICAL RELEVANCE: Gongjin-Dan is a representative traditional Oriental medicine herbal drug that has been used to treat chronic fatigue symptoms for several hundred years. We evaluated the anti-fatigue effects of Gongjin-Dan and the underlying mechanisms in a chronic forced exercise mouse model. METHODS AND MATERIALS: Balb/C male mice underwent an extreme treadmill-based running stress (1-h, 5 days/week), and daily oral administration of distilled water, Gongjin-Dan (100, 200, or 400 mg/kg), or ascorbic acid (100 mg/kg) for 28 days. The anti-fatigue effects of Gongjin-Dan were evaluated with behavioral tests (exercise tolerance and swimming tests), and the corresponding mechanisms were investigated based on oxidative stress and inflammatory cytokine and stress hormone levels in skeletal muscle, sera, and brain tissue. RESULTS: Gongjin-Dan significantly increased exercise tolerance and latency times but reduced the number of electric shocks and immobilization time on the treadmill running and swimming tests, compared with the control group. Gongjin-Dan also significantly ameliorated alterations in oxidative stress-related biomarkers (reactive oxygen species and malondialdehyde), inflammatory cytokines (tumor necrosis factor-α, interleukin-1 beta, interleukin-6, and interferon-γ) and glycogen and L-lactate levels in skeletal muscle, compared with those in the control group. Moreover, Gongjin-Dan considerably normalized the forced running stress-induced changes in serum corticosterone and adrenaline levels, as well as brain serotonin level. These antioxidant and anti-stress effects of Gongjin-Dan were supported by the results of Western blotting (4-hydroxynonenal and heme oxygenase-1) and the gene expression levels (serotonin receptor and serotonin transporter). CONCLUSION: These results support the clinical relevance of Gongjin-Dan regarding anti-chronic fatigue properties. The underlying mechanisms involve attenuation of oxidative and inflammatory reactions in muscle and regulation of the stress response through the hypothalmo-pituitary-adrenal axis.
Authors: Jin-Woo Jung; Seung Hwan Jeon; Woong Jin Bae; Su Jin Kim; Mun Su Chung; Byung Il Yoon; Sae Woong Choi; U Syn Ha; Sung Yeoun Hwang; Sae Woong Kim Journal: Chin J Integr Med Date: 2017-12-21 Impact factor: 1.978
Authors: Martina Svensson; Philip Rosvall; Antonio Boza-Serrano; Emelie Andersson; Jan Lexell; Tomas Deierborg Journal: Neurobiol Stress Date: 2016-09-09
Authors: Yurij I Prylutskyy; Inna V Vereshchaka; Andriy V Maznychenko; Nataliya V Bulgakova; Olga O Gonchar; Olena A Kyzyma; Uwe Ritter; Peter Scharff; Tomasz Tomiak; Dmytro M Nozdrenko; Iryna V Mishchenko; Alexander I Kostyukov Journal: J Nanobiotechnology Date: 2017-01-13 Impact factor: 10.435
Authors: Andriy V Maznychenko; Nataliya V Bulgakova; Inna V Sokolowska; Kamila Butowska; Agnieszka Borowik; Olena P Mankivska; Jacek Piosik; Tomasz Tomiak; Olga O Gonchar; Volodymyr O Maisky; Alexander I Kostyukov Journal: Sci Rep Date: 2020-06-17 Impact factor: 4.379
Authors: Mi Ju Son; Hwi-Jin Im; Boncho Ku; Jun-Hwan Lee; So Young Jung; Young-Eun Kim; Sung Bae Lee; Jun Young Kim; Chang-Gue Son Journal: Front Pharmacol Date: 2018-05-11 Impact factor: 5.810